Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Baseline neutrophil-to-eosinophil ratio and neutrophil-to-lymphocyte ratio as prognostic markers in patients with unresectable biliary tract cancer treated with gemcitabine-cisplatin-durvalumab: an international, multicentre, retrospective cohort study.
Journal: ESMO gastrointestinal oncology
Published: May 22, 2026
Bespoke Circulating Tumor DNA Testing for Diagnostic Resolution, Disease Surveillance, and Treatment Monitoring in Hepatopancreatobiliary Malignancies: A Real-World Experience.
Journal: JCO precision oncology
Published: April 09, 2026
Triple M overlap syndrome in the intensive care unit: differential diagnosis and management.
Journal: Critical care (London, England)
Published: March 24, 2026
Exploring the Role of Surgery After Systemic Therapy in Locally Advanced Biliary Tract Cancer: Outcomes From a Large Retrospective Multinational Real-World Cohort Treated With Cisplatin, Gemcitabine, and Durvalumab.
Journal: International journal of cancer
Published: March 23, 2026
Outcomes of Cisplatin, Gemcitabine, and Durvalumab According to TOPAZ-1 Study Eligibility: A Large Global Analysis in a Real-World Setting.
Journal: International journal of cancer
Published: February 15, 2026
Clinico-molecular characteristics and enhanced efficacy of immune checkpoint inhibitors in TP53-mutated advanced biliary tract cancer.
Journal: Journal of gastroenterology
Published: January 30, 2026
Survival outcomes with matched targeted therapy in advanced biliary tract cancer: a large global cohort analysis.
Journal: NPJ precision oncology
Published: December 11, 2025
Anlotinib and penpulimab in advanced hepatocellular carcinoma: a new contender emerges.
Journal: Journal of gastrointestinal oncology
Published: October 18, 2025
Beyond LEAP-015: the ongoing challenge of vascular endothelial growth factor inhibition in gastric cancer.
Journal: Journal of gastrointestinal oncology
Published: October 08, 2025
Prognostic Impact of Metastatic Sites in Patients with Biliary Tract Cancer Treated with Cisplatin, Gemcitabine, and Durvalumab.
Journal: Targeted oncology
Published: September 18, 2025
Last Updated: 09/26/2026